A growing number of US patients are travelling to Vilnius for regenerative therapies not yet broadly available in the United States.
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
This page covers what's most relevant for US patients specifically: where things stand today, travel logistics, and what to expect. For the broader picture of treatments, the medical team, and the patient journey, see our main Lithuania guide.
The US regulatory landscape for regenerative medicine is actively changing. Several states, including Florida, Utah, and Nevada, have begun creating their own legal pathways for limited regenerative therapy access, and the broader conversation about expanding access continues at both state and federal levels.
As Director of Outreach for the American Academy of Stem Cell Medicine (AASCM), Jed Ryan is part of a community of physicians, scientists, and advocates working toward a more favorable regulatory framework for stem cell and regenerative therapies in the United States. There is still significant work to be done.
In the meantime, there is a clear pathway for US patients who want access to advanced regenerative medicine and immunotherapy now: travel to an international destination where these treatments have been administered safely, in some cases for over 20 years. For many patients we work with, that destination is Innovita Clinic in Vilnius.
Most MSC stem cell therapies and exosome therapies are not currently FDA-approved. The FDA has approved a number of cell and gene therapies, primarily for cancer, blood disorders, and certain rare diseases. According to the FDA's own position, the only stem cell products currently approved for use in the United States are blood-forming stem cells derived from umbilical cord blood, used for hematopoietic reconstitution.
State-level laws in Florida, Utah, and Nevada have created limited domestic access pathways, but those pathways remain narrow in scope.
Patients who travel to Lithuania for treatment do so under EU and Lithuanian regulation, not under FDA jurisdiction. This is a different regulatory framework, with different evidence, manufacturing, and authorization standards. We don't represent that any treatment available in Vilnius is FDA-approved or available in the US.
What this means in practice for US patients:
Vilnius International Airport (VNO) is reached from the US by one connection through major European hubs. Most patients fly via:
Typical total travel times from the US:
For most US patients, treatment is combined with a longer trip, typically 5-10 days total, depending on protocol.
For full travel detail, including driver service, hotel recommendations, food, and communication, see the main Lithuania guide.
Innovita Clinic offers immunotherapy, regenerative medicine, and longevity protocols. Each is detailed on its own page; the categories below cover what's available.
A highly specific population of mesenchymal stem cells, selected and cultured in low-oxygen conditions to strengthen their stress-enduring qualities. They're used to repair tissue, calm an overactive immune system, and bring down inflammation, and they're the backbone of most protocols we coordinate.
Learn MoreTiny vesicles released by stem cells that carry signals between your cells. They're studied for tissue repair and immune modulation, and they're small enough to cross the blood-brain barrier, which can be a real advantage for neurological conditions.
Learn MoreShort chains of amino acids that signal specific processes in the body. Depending on the peptide, that can mean faster tissue healing, restoring hormonal balance, modulating the immune system, sharper metabolism, deeper sleep, or clearer cognition. We source and coordinate the ones that fit what you're working on.
Learn MoreVitamins, minerals, and antioxidants delivered straight into the bloodstream, where your body can use them right away. We run it on its own or alongside stem cell, exosome, and peptide protocols to support energy, recovery, and resilience.
Learn MoreBiological products like cord blood plasma, placenta cryoprecipitate, and concentrated growth factors. Many are birth-tissue-derived, rich in the proteins, cytokines, and growth factors the body uses to restore cellular function. Used on their own or alongside a protocol.
Learn MorePeople are unique, and more often than not so are the conditions they're dealing with. So most plans pair more than one therapy. Dr. Darinskas and his team combine stem cells, exosomes, peptides, and biologics around your specific case.
View All TreatmentsState-level legal pathways for regenerative therapy access vary. Florida, Utah, and Nevada have begun creating their own frameworks; specifics differ by jurisdiction and continue to evolve.